# Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design

Article · Donna H. Ryan, Ildiko Lingvay, Helen Martina Colhoun, John Eric Deanfield, Scott S. Emerson, Steven E. Kahn, Robert F. Kushner, Steve P. Marso, Jorge Plutzky, Kirstine Brown‐Frandsen, Marianne O. L. Gronning, G. Kees Hovingh, Anders Gaarsdal Holst, Henrik Ravn, Abraham Michael Lincoff

- Archive id: doi:10.1016/j.ahj.2020.07.008
- Published: 2020-07-17
- Venue: American Heart Journal
- DOI: https://doi.org/10.1016/j.ahj.2020.07.008
- PMID: 32916609
- Citations: 248
- Source URL: https://doi.org/10.1016/j.ahj.2020.07.008
- PDF: https://www.sciencedirect.com/science/article/pii/S0002870320302143/pdf
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [GLP-1 & Incretin Therapies](https://space-kitty.com/topics/glp1-metabolic)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.